Kristjan E. Paulson

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

Journal: Bone marrow transplantation

Published: February 23, 2026

Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.

Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: December 17, 2025

GVHD Prophylaxis With ATG and PTCy Versus PTCy-Based Regimens in Haploidentical Stem Cell Transplantation: A CTTC Study.

GVHD Prophylaxis With ATG and PTCy Versus PTCy-Based Regimens in Haploidentical Stem Cell Transplantation: A CTTC Study.

Journal: Transplantation and cellular therapy

Published: October 07, 2025

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Journal: Current oncology (Toronto, Ont.)

Published: October 02, 2025

Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.

Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: November 26, 2024

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Journal: Annals of hematology

Published: September 03, 2024

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Journal: Annals of hematology

Published: August 14, 2024

The role of registries in hematological disorders.

The role of registries in hematological disorders.

Journal: Best practice & research. Clinical haematology

Published: June 12, 2024

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.

Journal: Current oncology (Toronto, Ont.)

Published: January 14, 2024

Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.

Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.

Journal: Haematologica

Published: January 07, 2024

Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.

Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.

Journal: Current oncology (Toronto, Ont.)

Published: October 24, 2023

Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections.

Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 18, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026